1: Bedada SK, Neerati P. Resveratrol Pretreatment Affects CYP2E1 Activity of
Chlorzoxazone in Healthy Human Volunteers. Phytother Res. 2015 Dec 17. doi:
10.1002/ptr.5549. [Epub ahead of print] PubMed PMID: 26680654.
2: Raval MK, Patel JM, Parikh RK, Sheth NR. Dissolution enhancement of
chlorzoxazone using cogrinding technique. Int J Pharm Investig. 2015
Oct-Dec;5(4):247-58. doi: 10.4103/2230-973X.167689. PubMed PMID: 26682195; PubMed
Central PMCID: PMC4675006.
3: Tang P, Li S, Wang L, Yang H, Yan J, Li H. Inclusion complexes of
chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization,
dissolution, and cytotoxicity. Carbohydr Polym. 2015 Oct 20;131:297-305. doi:
10.1016/j.carbpol.2015.05.055. Epub 2015 Jun 4. PubMed PMID: 26256188.
4: Yamamura Y, Koyama N, Umehara K. Comprehensive kinetic analysis and influence
of reaction components for chlorzoxazone 6-hydroxylation in human liver
microsomes with CYP antibodies. Xenobiotica. 2015 Apr;45(4):353-60. doi:
10.3109/00498254.2014.985760. Epub 2014 Nov 19. PubMed PMID: 25815637.
5: Kumar S, Rani S, Siwach R, Verma P. To compare the efficacy and safety of
fixed dose combination of thiocolchicoside and aceclofenac versus chlorzoxazone,
aceclofenac and paracetamol in patients with acute lower backache associated with
muscle spasm. Int J Appl Basic Med Res. 2014 Jul;4(2):101-5. doi:
10.4103/2229-516X.136789. PubMed PMID: 25143885; PubMed Central PMCID:
PMC4137632.
6: Yurdakul S, Yurdakul M. FT-IR, FT-Raman spectra, and DFT computations of the
vibrational spectra and molecular geometry of chlorzoxazone. Spectrochim Acta A
Mol Biomol Spectrosc. 2014 May 21;126:339-48. doi: 10.1016/j.saa.2014.02.156.
Epub 2014 Mar 12. PubMed PMID: 24684869.
7: Zhang J, Chen G, Tian M, Li R, Quan X, Jia Q. A novel organic-inorganic hybrid
monolithic column prepared in-situ in a microchip and its application for the
determination of 2-amino-4-chlorophenol in chlorzoxazone tablets. Talanta. 2013
Oct 15;115:801-5. doi: 10.1016/j.talanta.2013.06.058. Epub 2013 Jul 4. PubMed
PMID: 24054665.
8: Feil K, Claaßen J, Bardins S, Teufel J, Krafczyk S, Schneider E, Schniepp R,
Jahn K, Kalla R, Strupp M. Effect of chlorzoxazone in patients with downbeat
nystagmus: a pilot trial. Neurology. 2013 Sep 24;81(13):1152-8. doi:
10.1212/WNL.0b013e3182a55f6d. Epub 2013 Aug 23. PubMed PMID: 23975871.
9: Aybaba C, Palabiyik IM, Caglayan MG, Onur F. Multivariate optimization of
separation conditions for simultaneous determination of acemetacin and
chlorzoxazone in a pharmaceutical preparation by HPLC using response surface
methodology. J AOAC Int. 2013 Jul-Aug;96(4):723-9. PubMed PMID: 24000743.
10: Abdelaleem EA, Abdelwahab NS. Stability-indicating TLC-densitometric method
for simultaneous determination of paracetamol and chlorzoxazone and their toxic
impurities. J Chromatogr Sci. 2013 Feb;51(2):187-91. doi:
10.1093/chromsci/bms125. Epub 2012 Jul 26. PubMed PMID: 22843763.
11: Zhai X, Lu Y. Development and validation of a simple LC method for the
determination of phenacetin, coumarin, tolbutamide, chlorzoxazone, testosterone
and their metabolites as markers of cytochromes 1A2, 2A6, 2C11, 2E1 and 3A2 in
rat microsomal medium. Pharmazie. 2013 Jan;68(1):19-26. PubMed PMID: 23444776.
12: Kwon MH, Lee CJ, Cho YY, Kang HE. Pharmacokinetics of a cytochrome P450 2E1
probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced
hyperlipidemic rats. J Pharm Pharm Sci. 2013;16(4):648-56. PubMed PMID: 24210069.
13: Gao N, Zou D, Qiao HL. Concentration-dependent inhibitory effect of Baicalin
on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe
substrate, in rats in vitro and in vivo. PLoS One. 2013;8(1):e53038. doi:
10.1371/journal.pone.0053038. Epub 2013 Jan 2. PubMed PMID: 23301016; PubMed
Central PMCID: PMC3534641.
14: Desai PP, Patel NR, Sherikar OD, Mehta PJ. Development and validation of
packed column supercritical fluid chromatographic technique for quantification of
chlorzoxazone, paracetamol and aceclofenac in their individual and combined
dosage forms. J Chromatogr Sci. 2012 Oct;50(9):769-74. doi:
10.1093/chromsci/bms059. Epub 2012 Jun 11. PubMed PMID: 22689898.
15: Attia MS, Ramsis MN, Khalil LH, Hashem SG. Spectrofluorimetric assessment of
chlorzoxazone and ibuprofen in pharmaceutical formulations by using
Eu-tetracycline HCl optical sensor doped in sol-gel matrix. J Fluoresc. 2012
Mar;22(2):779-88. doi: 10.1007/s10895-011-1013-1. Epub 2011 Nov 9. PubMed PMID:
22068956.
16: Shaik IH, Mehvar R. Effects of normothermic hepatic ischemia-reperfusion
injury on the in vivo, isolated perfused liver, and microsomal disposition of
chlorzoxazone, a cytochrome P450 2E1 probe, in rats. J Pharm Sci. 2011
Dec;100(12):5281-92. doi: 10.1002/jps.22708. Epub 2011 Jul 20. PubMed PMID:
21780121.
17: Hopf FW, Simms JA, Chang SJ, Seif T, Bartlett SE, Bonci A. Chlorzoxazone, an
SK-type potassium channel activator used in humans, reduces excessive alcohol
intake in rats. Biol Psychiatry. 2011 Apr 1;69(7):618-24. doi:
10.1016/j.biopsych.2010.11.011. Epub 2010 Dec 31. PubMed PMID: 21195386; PubMed
Central PMCID: PMC3062269.
18: Wu JY, Yue J, Feng YQ. Determination of brain cytochrome P450 2E1 activity in
rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry. J
Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 1;879(3-4):260-6. doi:
10.1016/j.jchromb.2010.12.013. Epub 2010 Dec 21. PubMed PMID: 21196134.
19: Wiercinska P, Squires EJ. Chlorzoxazone metabolism by porcine cytochrome P450
enzymes and the effect of cytochrome b5. Drug Metab Dispos. 2010
May;38(5):857-62. doi: 10.1124/dmd.109.030528. Epub 2010 Feb 17. PubMed PMID:
20164110.
20: Jung HY, Kang HE, Choi YH, Kim SH, Lee MG. Time-dependent effects of
Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its
main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters
in 96 hour in KPLPS rats to control levels. Biopharm Drug Dispos. 2009
Nov;30(8):485-93. doi: 10.1002/bdd.685. PubMed PMID: 19753555.
